# Intravenous Iron in Adults With Cystic Fibrosis

> **NCT03632525** · PHASE4 · COMPLETED · sponsor: **University of Oxford** · enrollment: 20 (actual)

## Conditions studied

- Cystic Fibrosis
- Iron-deficiency

## Interventions

- **DRUG:** Ferric carboxymaltose

## Key facts

- **NCT ID:** NCT03632525
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-22
- **Primary completion:** 2020-03-27
- **Final completion:** 2021-10-26
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03632525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03632525, "Intravenous Iron in Adults With Cystic Fibrosis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03632525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*